We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

Back to rankings

201 hedge funds and large institutions have $1.14B invested in DIPLOMAT PHARMACY, INC. in 2018 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 63 increasing their positions, 73 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $960M → $1.14B (+$177M)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

2% more call options, than puts

Call options by funds: $3.94M | Put options by funds: $3.88M

1% more funds holding

Funds holding: 200 → 201 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

14% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 73

Holders
201
Holders Change
+1
Holders Change %
+0.5%
% of All Funds
4.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
38
Increased
63
Reduced
73
Closed
35
Calls
$3.94M
Puts
$3.88M
Net Calls
+$60K
Net Calls Change
+$1.09M

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$118M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.5M
4
RI
Redwood Investments
Massachusetts
+$19.4M
5
Millennium Management
Millennium Management
New York
+$17.4M

Top Sellers

Rank Fund Capital Flow
1
DSA
Davis Selected Advisers
Arizona
-$30.7M
2
RP
Riverbridge Partners
Minnesota
-$15M
3
Victory Capital Management
Victory Capital Management
Texas
-$11.5M
4
CAM
Cortina Asset Management
Wisconsin
-$11.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
$11.9M +$13.8M +592,819 New
HRCM
27
Hood River Capital Management
Florida
$11.9M +$13.8M +589,397 New
DSA
28
Davis Selected Advisers
Arizona
$9.7M -$30.7M -1,317,941 -73%
PI
29
Putnam Investments
Massachusetts
$9.3M +$10.8M +461,480 New
Goldman Sachs
30
Goldman Sachs
New York
$8.86M +$5.45M +233,630 +113%
TCM
31
Tekla Capital Management
Massachusetts
$8.85M -$4.7M -201,491 -31%
State of Wisconsin Investment Board
32
State of Wisconsin Investment Board
Wisconsin
$8.18M +$1.81M +77,683 +24%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$8.08M -$1.05M -44,975 -10%
Bank of America
34
Bank of America
North Carolina
$7.95M -$5.67M -242,928 -38%
Charles Schwab
35
Charles Schwab
California
$7.87M +$903K +38,684 +11%
TCIM
36
TIAA CREF Investment Management
New York
$7.48M +$97.7K +4,186 +1%
Principal Financial Group
37
Principal Financial Group
Iowa
$7.44M +$193K +8,258 +2%
PCM
38
Palisade Capital Management
New Jersey
$7.41M +$3.25M +139,174 +61%
TA
39
Teachers Advisors
New York
$6.16M +$180K +7,734 +3%
BA
40
Broadview Advisors
Wisconsin
$5.92M -$1.03M -43,950 -13%
Invesco
41
Invesco
Georgia
$5.67M +$1.82M +78,019 +38%
Ameriprise
42
Ameriprise
Minnesota
$5.64M -$5.68M -243,370 -47%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$5.23M -$7.04M -301,658 -54%
LCM
44
Laurion Capital Management
New York
$4.67M +$5.4M +231,490 New
CM
45
Castleark Management
Illinois
$4.11M +$4.76M +204,140 New
CIAS
46
Capital Investment Advisory Services
North Carolina
$4M +$4.64M +198,682 New
Norges Bank
47
Norges Bank
Norway
$3.88M – – –
Morgan Stanley
48
Morgan Stanley
New York
$3.67M -$4.53M -194,067 -52%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$3.45M +$903K +38,707 +29%
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
$3.41M +$152K +6,525 +4%
1
2
3 4 5

DPLO Hedge Fund Activity: Q1 2018 in Review

201 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2018, worth a combined $1.14B — up 18% from $960M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new DPLO positions and 35 closed out — a net gain of 3 holders — while 63 added to existing stakes and 73 trimmed.

The largest buyer was Capital World Investors, adding an estimated $118M. The largest seller was Davis Selected Advisers, cutting an estimated $30.7M.

  • 201 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2018, up from 200 in Q4 2017.
  • Funds reported $1.14B of DIPLOMAT PHARMACY, INC. stock for Q1 2018, up 18% quarter-over-quarter.
  • 38 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2018 and 35 closed out, a net change of +3 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2018 was Capital World Investors, an estimated $118M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q1 2018 was Davis Selected Advisers, an estimated $30.7M sold.

Based on aggregated 13F filings for Q1 2018.